Clik here to view.
BioDelivery’s topical gel for diabetic neuropathy fails in phase IIb trial
BioDelivery Sciences International (NSDQ:BDSI) said today that its clonidine topical gel for pain relief in patients with diabetic neuropathy failed in a phase IIb clinical trial. Raleigh, N.C.-based...
View ArticleClik here to view.
Endologix AFX CE Mark suspended over endoleak issues
Endologix (NSDQ:ELGX) said yesterday that the CE Mark approval of its AFX abdominal aortic aneurysm system will be suspended over reports of type III endoleaks with a previous-gen version of the...
View ArticleClik here to view.
Silk Road touts low stroke rate in 2 studies of Enroute TCAR system
Silk Road Medical yesterday released data from 2 studies of its Enroute transcarotid neuroprotection and stent system, including 1-year data from a pivotal trial of the device and an interim analysis...
View ArticleClik here to view.
AcelRx seeks FDA nod for non-invasive sufentanil painkiller
AcelRx Pharmaceuticals (NSDQ:ACRX) said today that it submitted a new drug application to the FDA for its ARX-04 sublingual sufentanil tablet. The non-invasive compound has been studied as a treatment...
View ArticleClik here to view.
J&J’s Codman Neuro picks up Pulsar Vascular
Johnson & Johnson‘s (NYSE:JNJ) Codman Neuro said last week it picked up Pulsar Vascular, which produces the PulseRider device for treating brain aneurysms, for an undisclosed amount. The PulseRider...
View ArticleClik here to view.
Rewired immune cells respond as targeted cancer therapy
Researchers from Northwestern University have developed a method to rewire immune cells by genetically modifying the cells to sense molecules secreted by tumors and respond by activating the immune...
View ArticleClik here to view.
Spine stimulation helps man with spinal cord injury regain movement
Doctors from the Ronald Reagan UCLA Medical Center reported today that a spinal implant is helping return hand strength to a 28 year old man who suffered a spinal cord injury in 2011. The patient,...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for December 13, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Zimmer-Biomet prices $1B senior debt offering
Zimmer Biomet (NYSE:ZBH) recently priced an offering of Euro-dominated senior notes, looking to bring in over $1 billion. The company said it will offer $530 million (EU €500 million) principal amount...
View ArticleClik here to view.
Intuitive Surgical boosts share repurchasing program to $3B
Intuitive Surgical (NSDQ:ISRG) said today its board of directors has increased the authorized amount available under its share repurchase program to $3 billion. The Pleasanton, Calif.-based company...
View ArticleClik here to view.
Lumendi wins FDA 510(k) for DiLumen endoscope positioning accessory
Medical device developer Lumendi said today it won FDA 510(k) clearance for its DiLumen endoscopic accessory. The Connecticut-based company’s DiLumen device is now indicated for use in positioning...
View ArticleClik here to view.
The history of clinical research
For research professionals involved in clinical trials, there is an immense responsibility of protecting human subjects, but history has taught us, unethical practice and disregard for the well-being...
View ArticleClik here to view.
Actelion, Sanofi in talks after J&J backs out of negotiations
Actelion (VTX:ATLN) and Sanofi (NYSE:SNY) are reportedly in talks to reach a takeover deal after Johnson & Johnson (NYSE:JNJ) said yesterday that it has closed negotiations with the Swiss biotech....
View ArticleClik here to view.
FDA approves first bioresorbable scaffold with autologous cells for cartilage...
Vericel Corp (NSDQ:VCEL) shares soared 56% today after the Cambridge, Mass.-based company said the FDA approved its bioresorbable scaffold for cartilage repair. The product, Maci, is the 1st...
View ArticleClik here to view.
Obama signs 21st Century Cures Act
President Obama yesterday signed the 21st Century Cures Act into law, the last step for the bill which has been 2 years in the making. Last week, the U.S. Senate voted 94-5 to pass the 21st Century...
View ArticleClik here to view.
Eli Lilly, Express Scripts offer insulin discount program
Eli Lilly (NYSE:LLY) said it is teaming up with pharmacy benefit manager Express Scripts (NSDQ:ESRX) to offer discounts on the US pharma giant’s insulin products for uninsured patients and people with...
View ArticleClik here to view.
Siemens invests $300m in Walpole, Mass facility
Siemens Healthineers (NYSE:SI) said today it is investing approximately $300 million over 4 years into its Walpole, Mass.-based laboratory diagnostics manufacturing and R&D facility. The Walpole...
View ArticleClik here to view.
Zimmer Biomet closes $1B senior debt offering
Zimmer Biomet (NYSE:ZBH) said today it closed its an offering of Euro-dominated senior notes, bringing in over $1 billion. The company brought in $530 million (EU €500 million) in principal amount of...
View ArticleClik here to view.
Bioventus picks up US Durolane rights from Galderma
Bioventus said today it inked a deal to pick up the U.S. rights for Durolane joint lubrication from Galderma for an undisclosed amount. Galderma’s Durolane is a single-injection, hyaluornic acid...
View ArticleClik here to view.
AARP report details increase in brand name drug prices
The AARP Public Policy Institute released a report today showing that 2015 was the 4th straight year of double-digit average annual increases for widely used brand name drugs. The nonprofit...
View Article
